Nociception Level During Opioid-sparing Anaesthesia Versus Conventional Opioid-based Anaesthesia

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 17, 2022

Primary Completion Date

February 8, 2024

Study Completion Date

February 8, 2024

Conditions
Analgesia
Interventions
DRUG

conventional opioid-based group

In addition to propofol as a hypnotic and rocuronium as a muscle relaxant, patients in the conventional opioid-based group will receive the following drugs: Remifentanil and Fentanyl

DRUG

opioid-sparing group

In addition to propofol as a hypnotic and rocuronium as a muscle relaxant, patients in the opioid-sparing group will receive Ketamine, Fentanyl, Lidocaine, Magnesium, Clonidine, Remifentanil

Trial Locations (1)

4031

Department of Anaesthesiology, University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT05485480 - Nociception Level During Opioid-sparing Anaesthesia Versus Conventional Opioid-based Anaesthesia | Biotech Hunter | Biotech Hunter